US Broker Ratings

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the competitive biotechnology sector with its focus on developing and commercializing innovative medicines in the United States. With a market capitalization of..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering player in the biotech industry, is capturing investor attention with its robust potential upside of 147.02%. Specializing in cutting-edge cell engineering platforms, Sana..

Tilray Brands, Inc. (TLRY) Investor Outlook: Potential Upside of Nearly 48% Amid Diverse Product Portfolio

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector and a leader in the drug manufacturing industry, is a focal point for investors seeking promising opportunities within..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 128% Potential Upside in Biotech Innovation

For investors with a keen interest in the biotechnology sector, Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity, offering an impressive 128.25% potential upside according to analyst ratings. This clinical-stage..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Gem with a 72% Upside Potential

Investors looking for promising opportunities in the biotechnology sector may want to consider Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company that is pioneering T cell redirecting immunotherapies for cancer..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 57.73% Potential Upside in the Medical Instruments Space

Embecta Corp. (NASDAQ: EMBC), a significant player in the healthcare sector’s medical instruments and supplies industry, offers an intriguing investment opportunity with its current market dynamics. With a market capitalization..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Promising 174% Upside in Genetic Medicines

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its strong potential upside in the realm of genetic medicines. As a clinical-stage biotechnology company, MeiraGTx is at..

Stoke Therapeutics (STOK) Stock Analysis: Biotech Innovator with 27.62% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a cutting-edge player in the biotechnology sector, is capturing investor attention with its groundbreaking approach to addressing severe genetic diseases. With a current market capitalization..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 136.90% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, offers a unique software-as-a-service (SaaS) healthcare commercial intelligence platform. This Massachusetts-based company, founded in 2011, provides..

Sonida Senior Living, Inc. (SNDA): Investor Outlook Reveals Strategic Position in Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in providing a range of senior housing solutions across the..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating the Healthcare Sector with a -16.37% Potential Downside

InnovAge Holding Corp. (NASDAQ: INNV) is a notable player in the healthcare sector, specifically in the medical care facilities industry. Based in Denver, Colorado, InnovAge is a provider of comprehensive..

iRadimed Corporation (IRMD) Stock Analysis: Strong Buy Ratings and 29% Upside Potential

Investors eyeing the healthcare sector might find iRadimed Corporation (IRMD) an intriguing opportunity, given its specialized niche in the medical devices industry. With a market capitalization of $1.17 billion, this..

Oculis Holding AG (OCS) Stock Analysis: A Promising Biotech with a 74.79% Potential Upside

Oculis Holding AG (NASDAQ: OCS), a Switzerland-based clinical-stage biopharmaceutical company, is attracting significant attention from investors with its robust pipeline of drug candidates targeting ophthalmic and neurological diseases. The company’s..

Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating a 39% Upside Potential Amid Industry Challenges

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the medical technology..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 139.88% Potential Upside in the Biotech Arena

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, is garnering significant attention in the investment community for its promising prospects in the biotechnology sector. Specializing in the development of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a Potent 412.82% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a biopharmaceutical company making strides in the treatment of liver diseases, has captured the attention of investors with its notable 412.82% potential upside. As the company..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Potential Upside of 55.83% Signals Strong Growth Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention in the biotechnology sector with its promising pipeline focused on transformative cell and exosome-based therapies. Headquartered in San Diego, California, this clinical-stage..

Beta Bionics, Inc. (BBNX) Stock Analysis: 84% Upside Potential Fuels Investor Interest

Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions for managing diabetes. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds